Gallagher seeks to end U.S. drug supply chain’s reliance on China
U.S. Rep. Mike Gallagher, R-Green Bay, introduced legislation last week that would ban the use of federal funds for the purchase of medications that have ingredients made in China, a policy that drugmakers warn could disrupt the drug supply chain.
To access this content, you must purchase a Premium membership, or log in if you are a member.
